Clinical Trial Update: Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a cancer vaccine therapy in combination with Interleukin-2 for relapsed or refractory Ewing sarcoma or Neuroblastoma in young …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Neuroblastoma

Drugs mentioned

• Aldesleukin (interleukin-2)
• Vaccine therapy

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Neuroblastoma, Sarcoma | Phase 1 | Status: UNKNOWN